Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

6

Number of overlapping holdings

12.5%

% of CANC's 48 holdings also in PTH

17.1%

% of PTH's 35 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus PTH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in PTH
Overlap
ELI LILLY & CO 5.4% 4.3% 4.3%
EXELIXIS INC 3.8% 4.0% 3.8%
BRIDGEBIO PHARMA, INC. 4.5% 3.3% 3.3%
ABBVIE INC 1.9% 3.0% 1.9%
GUARDANT HEALTH, INC. 0.7% 3.5% 0.7%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PTH
REVOLUTION MEDICINES, INC. 5.7%
ROCHE HOLDINGS LTD-SPONS ADR 5.1%
NOVARTIS AG 4.3%
ASTRAZENECA PLC 4.2%
BRISTOL-MYERS SQUIBB CO 4.0%
NUVALENT, INC. CLASS A 3.9%
SUMMIT THERAPEUTICS INC 3.9%
GENMAB A/S SPONSORED ADR 3.4%
MERUS N.V. 3.2%
ZAI LAB LTD. UNSPONSORED ADR 3.0%
CANC Underweight Relative to PTH
CENCORA INC -4.5%
ALIGNMENT HEALTHCARE, INC. -3.9%
TG THERAPEUTICS INC -3.7%
BOSTON SCIENTIFIC CORP -3.6%
KRYSTAL BIOTECH, INC. -3.5%
INSMED INC -3.4%
AXSOME THERAPEUTICS, INC. -3.3%
MADRIGAL PHARMACEUTICALS, INC. -3.2%
RESMED INC -3.1%
MERIT MEDICAL SYSTEMS INC -3.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY